Evolva reaches third milestone in Roquette collaboration
Evolva (SIX: EVE) today announces the achievement of the third milestone in its collaboration with Roquette Frères SA (Roquette).
Evolva has delivered a production yeast strain for the target food ingredient that matches Roquette’s expectations, triggering a milestone payment of several hundreds of thousands of Swiss Francs to Evolva. An improved version of the strain is expected to be delivered later this year, completing the programme.
Thierry Marcel, Executive Vice President Research & Development of Roquette said, “When we started working with Evolva, back in early 2012, we were hoping to see fresh impulses in our search for innovative solutions and improved processes. Looking at the achievements to date, I conclude that Evolva has done an impressive job and I am looking forward to further progress and the successful completion of the project.”
Neil Goldsmith, CEO of Evolva added, “This project is another confirmation of our fermentation technology’s ability to deliver competitive products and processes to our partners. It is a pleasure working with the Roquette team, with whom we share a commitment to innovation and sustainability.”
– Ends –
Evolva is a pioneer and global leader in sustainable, fermentation-based approaches to ingredients for health, wellness and nutrition. Evolva’s products include stevia, resveratrol, vanillin, nootkatone and saffron. As well as developing its own proprietary ingredients, Evolva also deploys its technology for partners, providing them with a competitive edge and sharing in the returns they make. For more information see www.evolva.com. Questions about our fermentation approach? Have a look at our video
+ 41 61 485 2005
|Jakob Dynnes Hansen
+ 41 61 485 2034
+ 41 61 485 2035
THIS PRESS RELEASE CONTAINS SPECIFIC FORWARD-LOOKING STATEMENTS, E.G. STATEMENTS INCLUDING TERMS LIKE BELIEVE, ASSUME, EXPECT OR SIMILAR EXPRESSIONS. SUCH FORWARD LOOKING STATEMENTS ARE SUBJECT TO KNOWN AND UNKNOWN RISKS, UNCERTAINTIES AND OTHER FACTORS WHICH MAY RESULT IN A SUBSTANTIAL DIVERGENCE BETWEEN THE ACTUAL RESULTS, FINANCIAL SITUATION, DEVELOPMENT OR PERFORMANCE OF THE COMPANY AND THOSE EXPLICITLY OR IMPLICITLY PRESUMED IN THESE STATEMENTS. AGAINST THE BACKGROUND OF THESE UNCERTAINTIES READERS SHOULD NOT PLACE UNDUE RELIANCE ON FORWARD-LOOKING STATEMENTS OR TO ADAPT THEM TO FUTURE EVENTS OR DEVELOPMENTS.
Stay informed Join our mailing list to receive Evolva’s press releases via e-mail.Join